ClinConnect ClinConnect Logo
Search / Trial NCT06003686

Spinal Cord Injury Model Systems (SCIMS) - Education Module

Launched by UNIVERSITY OF MIAMI · Aug 16, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The Spinal Cord Injury Model Systems (SCIMS) study is looking to understand if education about the health risks related to obesity and cardiometabolic diseases can help people with spinal cord injuries (SCI) improve their health. The goal is to see if learning about these risks can help participants better manage their health after their injury.

To participate in this study, you should be between 18 and 70 years old, have a spinal cord injury classified as complete or incomplete (levels C5 and below), and have been discharged from rehabilitation within the last four months. Unfortunately, if you are pregnant, have serious cognitive issues that might affect your ability to give consent, have severe pressure injuries, or are currently incarcerated, you won't be eligible to join. If you decide to participate, you can expect to receive important information that could help you understand and manage your health risks better.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Men and Women with SCI/D aged 18-70 years.
  • 2. Neurologically complete and incomplete American Spinal Injury Association (ASIA) Impairment scale (AIS) A-D spinal cord levels C5 and below.
  • 3. Enrolled no later than 4 months following discharge from initial rehabilitation from SCI.
  • Exclusion Criteria:
  • 1. Pregnancy determined by urine testing in sexually active females.
  • 2. Cognitive impairment that compromises the legitimacy of consent.
  • 3. Grade 3-4 pressure injury at the time of study entry.
  • 4. Prisoners

About University Of Miami

The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.

Locations

Washington, District Of Columbia, United States

Miami, Florida, United States

Minneapolis, Minnesota, United States

Dallas, Texas, United States

Richmond, Virginia, United States

Patients applied

0 patients applied

Trial Officials

Gary Farkas, PhD

Principal Investigator

University of Miami

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported